This website is currently on accessible from desktops.

September 2020
PHARMALINE UNVEILS NEW MEDICAMENT FOR THE TREATMENT OF OSTEOPOROSIS
Share On

With a mission to always find new ways to improve patients’ quality of life, Malia Group’s pharmaceutical company, Pharmaline, recently launched Bonafor. Prescribed among the first-line of therapies for the management of Post-Menopausal Osteoporosis, Bonafor improves and preserves bone mass, turnover, and architecture. It also boosts bone strength and protects against vertebral and non-vertebral fractures. It comes in easy-to-use one tablet per month format.

For more information on Pharmaline and its products, click here.



 

  • © 2021 Malia Group. All rights reserved
  • Follow us